These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis. Kerekes G; Soltész P; Dér H; Veres K; Szabó Z; Végvári A; Shoenfeld Y; Szekanecz Z Ann N Y Acad Sci; 2009 Sep; 1173():814-21. PubMed ID: 19758233 [TBL] [Abstract][Full Text] [Related]
3. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. Sarzi-Puttini P; Atzeni F; Shoenfeld Y; Ferraccioli G Autoimmun Rev; 2005 Mar; 4(3):153-61. PubMed ID: 15823501 [TBL] [Abstract][Full Text] [Related]
4. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. Galarraga B; Belch JJ; Pullar T; Ogston S; Khan F J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Dessein PH; Joffe BI; Singh S Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050 [TBL] [Abstract][Full Text] [Related]
6. Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy. González-Gay MA; González-Juanatey C; Miranda-Filloy JA; García-Unzueta MT; Llorca J Acta Reumatol Port; 2012; 37(2):155-9. PubMed ID: 23149638 [TBL] [Abstract][Full Text] [Related]
7. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis. Cardillo C; Schinzari F; Mores N; Mettimano M; Melina D; Zoli A; Ferraccioli G Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy. Gonzalez-Gay MA; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Llorca J Ann N Y Acad Sci; 2010 Apr; 1193():153-9. PubMed ID: 20398022 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Avouac J; Allanore Y Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987 [TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Gonzalez-Gay MA; Gonzalez-Juanatey C; Martin J Semin Arthritis Rheum; 2005 Aug; 35(1):8-17. PubMed ID: 16084219 [TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Van Doornum S; McColl G; Wicks IP Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882 [TBL] [Abstract][Full Text] [Related]
14. Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors. Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S J Rheumatol; 2012 Jul; 39(7):1341-7. PubMed ID: 22660798 [TBL] [Abstract][Full Text] [Related]
15. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512 [TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107 [TBL] [Abstract][Full Text] [Related]
17. How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear? Kerola AM; Kauppi MJ; Kerola T; Nieminen TV Ann Rheum Dis; 2012 Oct; 71(10):1606-15. PubMed ID: 22736093 [TBL] [Abstract][Full Text] [Related]
18. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk in rheumatoid arthritis: how to lower the risk? van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429 [TBL] [Abstract][Full Text] [Related]